Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Liver-specific deceased donor risk indices.

Wang Z, Hisatake G, Yang L.

Hepatol Res. 2014 Feb;44(2):159-64. doi: 10.1111/hepr.12228. Epub 2013 Oct 18.

PMID:
24033790
2.

De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population.

Prieto M, Gómez MD, Berenguer M, Córdoba J, Rayón JM, Pastor M, García-Herola A, Nicolás D, Carrasco D, Orbis JF, Mir J, Berenguer J.

Liver Transpl. 2001 Jan;7(1):51-8.

3.

Infectivity of hepatic allografts with antibodies to hepatitis B virus.

Dodson SF, Issa S, Araya V, Gayowski T, Pinna A, Eghtesad B, Iwatsuki S, Montalvo E, Rakela J, Fung JJ.

Transplantation. 1997 Dec 15;64(11):1582-4.

PMID:
9415560
4.

Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy.

Yu AS, Vierling JM, Colquhoun SD, Arnaout WS, Chan CK, Khanafshar E, Geller SA, Nichols WS, Fong TL.

Liver Transpl. 2001 Jun;7(6):513-7.

5.

Liver grafts from anti-hepatitis B core positive donors: a systematic review.

Cholongitas E, Papatheodoridis GV, Burroughs AK.

J Hepatol. 2010 Feb;52(2):272-9. doi: 10.1016/j.jhep.2009.11.009. Epub 2010 Jan 19. Review.

6.

Use of anti-HBc positive allografts in adult liver transplantation: toward a safer way to expand the donor pool.

Donataccio D, Roggen F, De Reyck C, Verbaandert C, Bodeus M, Lerut J.

Transpl Int. 2006 Jan;19(1):38-43.

7.

Transplantation of livers from hbc Ab positive donors into HBc Ab negative recipients: a strategy and preliminary results.

Loss GE, Mason AL, Blazek J, Dick D, Lipscomb J, Guo L, Perrillo RP, Eason JD.

Clin Transplant. 2001;15 Suppl 6:55-8.

PMID:
11903388
8.

Subclinical reactivation of hepatitis B virus in liver transplant recipients with past exposure.

Abdelmalek MF, Pasha TM, Zein NN, Persing DH, Wiesner RH, Douglas DD.

Liver Transpl. 2003 Dec;9(12):1253-7.

9.

Hepatitis B virus infection in heart transplant recipients in a hepatitis B endemic area.

Ko WJ, Chou NK, Hsu RB, Chen YS, Wang SS, Chu SH, Lai MY.

J Heart Lung Transplant. 2001 Aug;20(8):865-75.

PMID:
11502409
10.

Antibodies to hepatitis B surface antigen prevent viral reactivation in recipients of liver grafts from anti-HBC positive donors.

Roque-Afonso AM, Feray C, Samuel D, Simoneau D, Roche B, Emile JF, Gigou M, Shouval D, Dussaix E.

Gut. 2002 Jan;50(1):95-9.

11.

Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allografts.

Khapra AP, Agarwal K, Fiel MI, Kontorinis N, Hossain S, Emre S, Schiano TD.

Liver Transpl. 2006 Oct;12(10):1496-503.

12.

Outcomes of liver transplantation in simultaneously hepatitis B surface antigen and hepatitis C virus RNA positive recipients: the deleterious effect of donor hepatitis B core antibody positivity.

Tandoi F, Romagnoli R, Martini S, Mazza E, Nada E, Cocchis D, Lupo F, Salizzoni M.

Transplant Proc. 2012 Sep;44(7):1960-2. doi: 10.1016/j.transproceed.2012.07.061.

PMID:
22974882
13.

The biopsied donor liver: incorporating macrosteatosis into high-risk donor assessment.

Spitzer AL, Lao OB, Dick AA, Bakthavatsalam R, Halldorson JB, Yeh MM, Upton MP, Reyes JD, Perkins JD.

Liver Transpl. 2010 Jul;16(7):874-84. doi: 10.1002/lt.22085.

14.

High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.

Su WJ, Ho MC, Ni YH, Chen HL, Hu RH, Wu YM, Chang MH, Lee PH.

J Pediatr Gastroenterol Nutr. 2009 Feb;48(2):203-8. doi: 10.1097/MPG.0b013e3181819ad4.

PMID:
19179883
15.

Survival after orthotopic liver transplantation: the impact of antibody against hepatitis B core antigen in the donor.

Yu L, Koepsell T, Manhart L, Ioannou G.

Liver Transpl. 2009 Oct;15(10):1343-50. doi: 10.1002/lt.21788.

16.

Transplanting kidneys from donors with prior hepatitis B infection: one response to the organ shortage.

Fabrizio F, Bunnapradist S, Martin P.

J Nephrol. 2002 Nov-Dec;15(6):605-13. Review.

PMID:
12495272
17.

The clinical course of transplantation-associated de novo hepatitis B infection in the liver transplant recipient.

Douglas DD, Rakela J, Wright TL, Krom RA, Wiesner RH.

Liver Transpl Surg. 1997 Mar;3(2):105-11.

18.

Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients.

Burra P, Loreno M, Russo FP, Germani G, Galligioni A, Senzolo M, Cillo U, Zanus G, Fagiuoli S, Rugge M.

Liver Transpl. 2009 Jun;15(6):619-28. doi: 10.1002/lt.21761.

19.
20.

Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.

Dickson RC, Everhart JE, Lake JR, Wei Y, Seaberg EC, Wiesner RH, Zetterman RK, Pruett TL, Ishitani MB, Hoofnagle JH.

Gastroenterology. 1997 Nov;113(5):1668-74.

PMID:
9352871

Supplemental Content

Support Center